Amneal Pharmaceuticals, Inc. Annual Operating Income (Loss) in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Amneal Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2016 to 2023.
  • Amneal Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was $88.8M, a 17.4% increase year-over-year.
  • Amneal Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was $188M, a 17% decline year-over-year.
  • Amneal Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was $204M.
  • Amneal Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$94.9M, a 162% decline from 2021.
  • Amneal Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was $153M, a 67.5% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.